Issue 2, 2019

Progress toward allosteric ligands of metabotropic glutamate 7 (mGlu7) receptor: 2008–present

Abstract

Metabotropic glutamate type 7 (mGlu7) receptor is a member of the group III family of mGlu receptors. It is widely distributed in the central nervous system (CNS) and is preferentially expressed on presynaptic nerve terminals where it is thought to play a critical role in modulating normal neuronal function and synaptic transmission, making it particularly relevant in neuropharmacology. The lack of small-molecule mGlu7 ligands with adequate potency, selectivity and drug-like properties has resulted in difficulties in the preclinical validation of mGlu7 modulation in disease models. In the last decade, allosteric modulators of mGlu7 receptors have emerged as valuable tools with good potency, selectivity and physicochemical properties to study and unleash the therapeutic potential of mGlu7 receptors. This review focusses on the medicinal chemistry of mGlu7 receptor allosteric ligands discovered since 2008.

Graphical abstract: Progress toward allosteric ligands of metabotropic glutamate 7 (mGlu7) receptor: 2008–present

Article information

Article type
Review Article
Submitted
17 Oct 2018
Accepted
11 Dec 2018
First published
12 Dec 2018

Med. Chem. Commun., 2019,10, 193-199

Progress toward allosteric ligands of metabotropic glutamate 7 (mGlu7) receptor: 2008–present

H. Vázquez-Villa and A. A. Trabanco, Med. Chem. Commun., 2019, 10, 193 DOI: 10.1039/C8MD00524A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements